You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0479 The role of antibodies to xanthine oxidase and adenosine deaminase in the development of anti-phospholipid syndrome in patients with systemic lupus erythematosus

Article info

Article menu

Download PDFPDF

Abstracts Accepted for Publication
SLE, Sjögren's and APS - clinical aspects (other than treatment)
AB0479 The role of antibodies to xanthine oxidase and adenosine deaminase in the development of anti-phospholipid syndrome in patients with systemic lupus erythematosus
Free

Authors

Citation

Aleksandrov A, Alekhina I, Aleksandrova N, et al
AB0479 The role of antibodies to xanthine oxidase and adenosine deaminase in the development of anti-phospholipid syndrome in patients with systemic lupus erythematosus
Annals of the Rheumatic Diseases 2017;76:1218.

Publication history

  • First published June 15, 2017.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions